Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

996
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
996
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

642
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
642
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

363
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
363

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opioid Prescribing by US Dentists and Dental Specialists after Continuing Education.

JDR clinical and translational research·2026
Same author

Milk in Fevers.

Daniel's Texas medical journal·2023
Same author

Performance and usability testing of an automated tool for detection of peripheral artery disease using electronic health records.

Scientific reports·2022
Same author

Comparing methods for estimation of heterogeneous treatment effects using observational data from health care databases.

Statistics in medicine·2018
Same author

Exposure To Potential Drug-Drug Interactions in Teaching Hospital Of South Punjab, Pakistan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Big Data and Adverse Drug Reaction Detection.

Clinical pharmacology and therapeutics·2015

Related Experiment Video

Updated: May 1, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.0K

Toward enhanced pharmacovigilance using patient-generated data on the internet.

R W White1, R Harpaz2, N H Shah2

  • 1Microsoft Research, Redmond, Washington, USA.

Clinical Pharmacology and Therapeutics
|April 10, 2014
PubMed
Summary

Analyzing internet search logs can help detect adverse drug reactions (ADRs). Combining this data with traditional reporting systems significantly improves ADR detection accuracy, enhancing patient safety.

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K
Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
11:21

Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data

Published on: July 27, 2018

8.0K

Related Experiment Videos

Last Updated: May 1, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.0K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K
Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
11:21

Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data

Published on: July 27, 2018

8.0K

Area of Science:

  • Pharmacovigilance and Pharmacoepidemiology
  • Computational Health Informatics
  • Digital Health and Big Data Analytics

Background:

  • Traditional pharmacovigilance relies on reporting systems like the US Food and Drug Administration's (FDA) Adverse Event Reporting System (AERS).
  • A scientific committee highlighted the potential of using patient-generated internet data to enhance pharmacovigilance practices.
  • There is a need to explore novel data sources for more robust adverse drug reaction (ADR) detection.

Purpose of the Study:

  • To investigate the feasibility and performance of using internet search log behavioral data for ADR detection.
  • To compare the effectiveness of search log data against traditional AERS data for identifying adverse drug reactions.
  • To assess the benefits of integrating internet search log data with existing pharmacovigilance systems.

Main Methods:

  • Analysis of anonymized internet search queries from 80 million consenting users.
  • Utilized a validated benchmark dataset for identifying and confirming adverse drug reactions.
  • Compared the performance of ADR detection models using search logs, AERS data, and a combined approach.

Main Results:

  • ADR detection performance using internet search logs was found to be comparable and complementary to the FDA's AERS.
  • Jointly analyzing data from AERS and internet search logs improved ADR detection accuracy by 19% compared to using either source alone.
  • Online search logs represent a valuable, nontraditional data source for pharmacovigilance.

Conclusions:

  • Internet search logs offer a promising supplementary data stream for augmenting current pharmacovigilance efforts.
  • Integrating behavioral data from online searches can significantly enhance the accuracy and comprehensiveness of ADR detection.
  • This approach supports the development of more proactive and effective drug safety monitoring systems.